Invention Grant
- Patent Title: Method of PLSCR inhibition for cancer therapy
- Patent Title (中): 癌症治疗PLSCR抑制方法
-
Application No.: US13452515Application Date: 2012-04-20
-
Publication No.: US08691229B2Publication Date: 2014-04-08
- Inventor: Err-Cheng Chan , Hong-Arh Fan , Kuei-Tien Chen , Yung-Bin Kuo , Jinn-Shiun Chen , Chung-Wei Fan
- Applicant: Err-Cheng Chan , Hong-Arh Fan , Kuei-Tien Chen , Yung-Bin Kuo , Jinn-Shiun Chen , Chung-Wei Fan
- Applicant Address: TW New Taipei
- Assignee: Err-Cheng CHAN
- Current Assignee: Err-Cheng CHAN
- Current Assignee Address: TW New Taipei
- Agency: Muncy, Geissler, Olds & Lowe, P.C.
- Main IPC: A61K38/00
- IPC: A61K38/00
Abstract:
The present invention relates to a method of using inhibitors of phospholipid scramblases (PLSCRs) for the prophylactic or therapeutic treatment of cancers. The PLSCR-inhibitors of the invention comprise compounds PLSCR-specific monoclonal antibodies, antagonists or nucleic acids, which have ability to decrease the level and/or biological activity of PLSCRs in cancer cells.
Public/Granted literature
- US20130280242A1 METHOD OF PLSCR INHIBITION FOR CANCER THERAPY Public/Granted day:2013-10-24
Information query
IPC分类:
